StockData
Parabilis Medicines, Inc. logo

Parabilis Medicines, Inc. (PBLS) stock

PBLSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026
$28.25−0.20 (-0.70%)

Close on Nov 17, 2026Market cap $3.49BP/E –Yield –

Parabilis Medicines enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Parabilis Medicines's enterprise value was $2.50B on Nov 11, 2026.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$2.50B–

More Parabilis Medicines figures

See a number that looks wrong?